|
Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea Clinical research trials and Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea. Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea clinical trial. Participants frequently get the best healthcare available for their Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea  Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
For Condition: Diabetes Mellitus
Status: No longer recruiting
Sponsor(s): Fujisawa Healthcare, Inc. ,
Synopsis: The purpose of the study is to assess the safety and efficacy of FK614 in type 2 diabetic subjects receiving sulfonylurea (SU) monotherapy.
Details: This is a prospective randomized, double-blind, placebo controlled, parallel group, Phase 2 study. Subjects meeting selection criteria will be randomly assigned to receive 12 weeks twice daily (BID) dosing with FK614 or placebo. Enrollment for this study will be approximately 200 patients.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 25 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - Has history of type 2 diabetes mellitus for at least 1 year - Has been taking current sulfonylurea (SU) for at least 3 months. Subjects currently taking metformin may be eligible to be switched. - Has not received any oral antidiabetic medication other than an SU or taken regularly prescribed insulin for at least 3 months Exclusion Criteria - Has type 1 diabetes mellitus - Has uncontrolled hypertension, i.e., systolic BP >170 or diastolic BP > 95 mm Hg. - History of congestive heart failure
Total Enrollment: 200
Location and Contact Information:
Baptist Diabetes Associates
Miami, Florida, 33176
United States
Research Foundation of America
Los Angeles, California, 90035
United States
Radiant Research - Minneapolis
Edina, Minnesota, 55435
United States
Physician's Office
Portland, Oregon, 97232
United States
Central Florida Clinical Studies
Ocoee, Florida, 34761
United States
OCCR @ East Gate Medical Center
Cypress, California, 90630
United States
International Institute of Clinical Research, Inc.
Ozark, Alabama, 36360
United States
The Emory Clinic
Atlanta, Georgia, 30322
United States
Fleetwood Medical Associates
Fleetwood, Pennsylvania, 19522
United States
SFM Clinical Trials
Scotland, Pennsylvania, 17254
United States
Progressive Clinical Research
Vista, California, 92083
United States
Center for Diabetes and Endocrine Care
Hollywood, Florida, 33021
United States
Baylor College of Medicine
Houston, Texas, 77030
United States
East-West Medical Institute
Honolulu, Hawaii, 96813
United States
McConnehey Family Medicine
Nampa, Idaho, 83651
United States
Arizona Research Associates
Tucson, Arizona, 85712
United States
Founders Research Corp.
Philadelphia, Pennsylvania, 19124
United States
Clireco, Inc.
Tamarac, Florida, 33321
United States
Sam Clinical Research Center
San Antonio, Texas, 78229
United States
Clinical Trials of St. Jude Heritage Md Grp
Fullerton, California, 92835
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
University of Miami, Diabetes Center
Miami, Florida, 33136
United States
Physicians for Clinical Research
Camp Hill, Pennsylvania, 17011
United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390
United States
Physician's East
Greenville, North Carolina, 27834
United States
University Physicians Internal Medicine
Huntington, West Virginia, 25701
United States
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598
United States
Mercury Research, Inc.
Houston, Texas, 77081
United States
Physician's Office
Peoria, Illinois, 61614
United States
Radiant Research
Mogadorf, Ohio, 44260
United States
Physician's Office
Miami, Florida, 33136
United States
Heartland Medical PC
New Tazewell, Tennessee, 37825
United States
Clinical Research, Inc.
Waltham, Massachusetts, 02453
United States
Diabetes / Glandular Disease Research Associates
San Antonio, Texas, 78229
United States
Physician's Office
Spokane, Washington, 99216
United States
McGuire Research Institute
Richmond, Virginia, 23249
United States
Additional Information:
Study ID Numbers: FA-614-0004;
Study Start Date: February 2002
Record last reviewed: April 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036192
Other Diabetes Mellitus Studies:
1. Prospective Controlled Study of Posttransplant Diabetes
2. Patterns and natural history of insulin secretion in islet cell transplant recipients and controls
3. Diabetes Therapy to Improve BMI and Lung Function in CF
4. Automated Calls with Nurse Follow-Up to Improve Diabetes Ambulatory Care
5. Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity with Type 2 Diabetes
Related Studies:
Other Diabetes Mellitus Clinical Trials
Other California Clinical Trials
Other Vista Clinical Trials
Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
|
|
|
|
|
|
|
|
